Please login or register first to view this content.
Oncology Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi’s sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
NEWS & FEATURES
Sitagliptin Promising Addition for Preventing Acute GVHD
Overall Survival Data Added to Nubeqa Prescribing Information
Statins May Benefit Patients Receiving ADT for Relapsed Prostate Cancer
Tiragolumab Gets Breakthrough Therapy Status for PD-L1-High NSCLC
Orgovyx Now Available for Advanced Prostate Cancer
Opdivo No Longer FDA-Approved for Small Cell Lung Cancer
Lorlatinib Under Review for Previously Untreated ALK-Positive NSCLC
Tagrisso Approved as Adjuvant Therapy for Early-Stage EGFR-Mutant NSCLC
Xpovio Multiple Myeloma Indication Expanded
Orgovyx Approved for Advanced Prostate Cancer
FDA Accepts and Grants Priority Review to New sBLA for Keytruda
Biosimilar Riabni Gets FDA Approval
Novel Breast Cancer Treatment Gains Approval
Pembrolizumab Slows MSI-H-dMMR Metastatic CRC
Treatment With High-Dose Melphalan Linked to Mutational Load in Multiple Myeloma
Gavreto Gets Accelerated Approval for RET-Altered Thyroid Cancers
Gallium 68 PSMA-11 Approved for Prostate Cancer Detection
Novel Treatment Gains Accelerated Approval for Relapsed/Refractory Neuroblastoma
